Case Report: Partial Uniparental Disomy Unmasks a Novel Recessive Mutation in the


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 03 11 2020
accepted: 16 03 2021
entrez: 19 4 2021
pubmed: 20 4 2021
medline: 15 9 2021
Statut: epublish

Résumé

Chédiak-Higashi syndrome (CHS) is a rare autosomal recessive (AR) immune disorder that has usually been associated to missense, nonsense or indels mutations in the

Identifiants

pubmed: 33868243
doi: 10.3389/fimmu.2021.625591
pmc: PMC8044466
doi:

Substances chimiques

LYST protein, human 0
Vesicular Transport Proteins 0

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

625591

Informations de copyright

Copyright © 2021 Boluda-Navarro, Ibáñez, Liquori, Franco-Jarava, Martínez-Gallo, Rodríguez-Vega, Teresa, Carreras, Such, Zúñiga, Colobran and Cervera.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Am J Hum Genet. 2019 Nov 7;105(5):921-932
pubmed: 31607426
Trends Mol Med. 2015 Feb;21(2):77-87
pubmed: 25547535
Front Immunol. 2018 Oct 16;9:2397
pubmed: 30386343
Eur J Hum Genet. 2014 Feb;22(2):197-201
pubmed: 23756439
Brain Dev. 2017 Feb;39(2):182-183
pubmed: 27639779
Blood. 2002 Oct 1;100(7):2367-73
pubmed: 12239144
Nat Rev Genet. 2019 Apr;20(4):235-248
pubmed: 30647469
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Clin Cancer Res. 2011 Jun 15;17(12):3913-23
pubmed: 21518781
Mol Cell. 2012 Nov 9;48(3):409-21
pubmed: 23000176
Am J Med Genet. 2002 Feb 15;108(1):16-22
pubmed: 11857544
Biol Cell. 2011 Jul;103(7):303-17
pubmed: 21651501
Am J Med Genet A. 2010 Jun;152A(6):1474-83
pubmed: 20503323
Eur J Hum Genet. 1999 Sep;7(6):633-7
pubmed: 10482950
Bioessays. 2000 May;22(5):452-9
pubmed: 10797485
Hum Mol Genet. 2010 Apr 1;19(7):1263-75
pubmed: 20053666
Cytogenet Genome Res. 2018;154(3):137-146
pubmed: 29656286
Traffic. 2013 Jul;14(7):749-66
pubmed: 23521701
Nat Genet. 1996 Nov;14(3):307-11
pubmed: 8896560
Eur J Haematol. 2014 Jan;92(1):49-58
pubmed: 24112114
Mol Genet Metab. 2005 Jun;85(2):125-32
pubmed: 15896657
Genet Med. 2020 Jul;22(7):1133-1141
pubmed: 32296163
Traffic. 2012 Jan;13(1):108-19
pubmed: 21985295
Leukemia. 1996 Feb;10(2):197-203
pubmed: 8637226
Mol Cytogenet. 2017 Oct 17;10:36
pubmed: 29075327
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10456-61
pubmed: 22689986
PLoS One. 2016 Aug 04;11(8):e0160519
pubmed: 27490490
Eur J Med Genet. 2013 Oct;56(10):546-50
pubmed: 23892181
Hum Genet. 2005 Jul;117(2-3):200-6
pubmed: 15887000
Blood. 2011 Oct 27;118(17):4620-9
pubmed: 21878672
Eur J Hum Genet. 1993;1(1):19-29
pubmed: 8069648
Genet Med. 2021 Jan 25;:
pubmed: 33495530
Am J Med Genet. 1980;6(2):137-43
pubmed: 7192492
Am J Med Genet A. 2007 Sep 15;143A(18):2172-7
pubmed: 17702006
Genet Med. 2020 Apr;22(4):803-808
pubmed: 31767986
Blood. 2017 Dec 21;130(25):2728-2738
pubmed: 28935695
Am J Hum Genet. 1998 Apr;62(4):848-54
pubmed: 9529353
J Allergy Clin Immunol. 2012 Nov;130(5):1144-1152.e11
pubmed: 22985903
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669

Auteurs

Mireia Boluda-Navarro (M)

Accredited Research Group in Hematology and Hemotherapy, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Mariam Ibáñez (M)

Accredited Research Group in Hematology and Hemotherapy, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Department of Hematology, Hospital Universitario y Politécnico La Fe, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Department of Medicine, University of Valencia, Valencia, Spain.
Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Valencia, Spain.

Alessandro Liquori (A)

Accredited Research Group in Hematology and Hemotherapy, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Clara Franco-Jarava (C)

Immunology Division, Hospital Universitari Vall d'Hebron (HUVH), Diagnostic Immunology, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain.

Mónica Martínez-Gallo (M)

Immunology Division, Hospital Universitari Vall d'Hebron (HUVH), Diagnostic Immunology, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain.

Héctor Rodríguez-Vega (H)

Pediatric Hematology Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Jaijo Teresa (J)

Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Carmen Carreras (C)

Pediatric Hematology Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Esperanza Such (E)

Department of Hematology, Hospital Universitario y Politécnico La Fe, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Ángel Zúñiga (Á)

Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Roger Colobran (R)

Immunology Division, Hospital Universitari Vall d'Hebron (HUVH), Diagnostic Immunology, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain.
Department of Clinical and Molecular Genetics, Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain.

José Vicente Cervera (JV)

Department of Hematology, Hospital Universitario y Politécnico La Fe, Barcelona, Spain.
Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH